E-ISSN 2636-834X
 

Original Research 


Retrospective Analysis of Patients with Disruptive Mood Dysregulation Disorder and Psychopharmacologic Treatment Preferences

Zehra Topal, Yusuf Ozturk, Ali Evren Tufan, Nuran Demir, Bengi Semerci.

Abstract
Background: DMDD is a new diagnosis listed in the DSM-5. Here, we aimed to present a retrospective analysis of cases with probable DMDD and their psychopharmacological treatment characteristics.
Methods: 200 patients complaining of “irritability” and “temper tantrums” were evaluated retrospectively. To differentiate those with probable DMDD; Young Mania Rating Scale, Children’s Depression Inventory, Screen for Anxiety and Related Disorders, Atilla Turgay Scale for DSM-IV-TR Disruptive Behavior Disorders scores were used.
Results: 99 patients were found to fulfill criteria for DMDD. 85 patients (87.6 %) were prescribed drugs. Most common drugs were risperidone, methylphenidate, atomoxetine, OROS methylphenidate, sertraline and fluoxetine in descending order. Females are more frequently prescribed SSRIs while males are prescribed other drugs
Conclusion: Because there is no treatment guidelines for DMDD yet, pharmacological treatment often targets core symptoms such as chronic irritability and outbursts of anger. İn this study female patients were more frequently prescribed fluoxetine while males prescribed more frequently other drugs such as methylphenidate and risperidone. Clinicians might determine more internalizing problems on female children and externalizing problems on males.

Key words: Disruptive Mood Dysregulation Disorder, irritability, temper tantrums, treatment


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Zehra Topal
Articles by Yusuf Ozturk
Articles by Ali Evren Tufan
Articles by Nuran Demir
Articles by Bengi Semerci
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

ZT, Ozturk Y, Tufan AE, Demir N, Semerci B. Retrospective Analysis of Patients with Disruptive Mood Dysregulation Disorder and Psychopharmacologic Treatment Preferences. PBS. 2021; 11(1): 1-7. doi:10.5455/PBS.20210223063506


Web Style

ZT, Ozturk Y, Tufan AE, Demir N, Semerci B. Retrospective Analysis of Patients with Disruptive Mood Dysregulation Disorder and Psychopharmacologic Treatment Preferences. https://www.pbsciences.org/?mno=302645370 [Access: December 15, 2023]. doi:10.5455/PBS.20210223063506


AMA (American Medical Association) Style

ZT, Ozturk Y, Tufan AE, Demir N, Semerci B. Retrospective Analysis of Patients with Disruptive Mood Dysregulation Disorder and Psychopharmacologic Treatment Preferences. PBS. 2021; 11(1): 1-7. doi:10.5455/PBS.20210223063506



Vancouver/ICMJE Style

ZT, Ozturk Y, Tufan AE, Demir N, Semerci B. Retrospective Analysis of Patients with Disruptive Mood Dysregulation Disorder and Psychopharmacologic Treatment Preferences. PBS. (2021), [cited December 15, 2023]; 11(1): 1-7. doi:10.5455/PBS.20210223063506



Harvard Style

, Z. T., Ozturk, . Y., Tufan, . A. E., Demir, . N. & Semerci, . B. (2021) Retrospective Analysis of Patients with Disruptive Mood Dysregulation Disorder and Psychopharmacologic Treatment Preferences. PBS, 11 (1), 1-7. doi:10.5455/PBS.20210223063506



Turabian Style

, Zehra Topal, Yusuf Ozturk, Ali Evren Tufan, Nuran Demir, and Bengi Semerci. 2021. Retrospective Analysis of Patients with Disruptive Mood Dysregulation Disorder and Psychopharmacologic Treatment Preferences. Psychiatry and Behavioral Sciences, 11 (1), 1-7. doi:10.5455/PBS.20210223063506



Chicago Style

, Zehra Topal, Yusuf Ozturk, Ali Evren Tufan, Nuran Demir, and Bengi Semerci. "Retrospective Analysis of Patients with Disruptive Mood Dysregulation Disorder and Psychopharmacologic Treatment Preferences." Psychiatry and Behavioral Sciences 11 (2021), 1-7. doi:10.5455/PBS.20210223063506



MLA (The Modern Language Association) Style

, Zehra Topal, Yusuf Ozturk, Ali Evren Tufan, Nuran Demir, and Bengi Semerci. "Retrospective Analysis of Patients with Disruptive Mood Dysregulation Disorder and Psychopharmacologic Treatment Preferences." Psychiatry and Behavioral Sciences 11.1 (2021), 1-7. Print. doi:10.5455/PBS.20210223063506



APA (American Psychological Association) Style

, Z. T., Ozturk, . Y., Tufan, . A. E., Demir, . N. & Semerci, . B. (2021) Retrospective Analysis of Patients with Disruptive Mood Dysregulation Disorder and Psychopharmacologic Treatment Preferences. Psychiatry and Behavioral Sciences, 11 (1), 1-7. doi:10.5455/PBS.20210223063506